The trademark application CRYPTOVAX was filed by (1) Epitopea Ltd, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant") and Epitopea Inc, a corporation established under the laws of Canada (the "Co-Applicant", and jointly with the "Applicant" referred to as the "Applicants" going forward). Application under examination.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Active chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines
Chemicals, reagents and substances for medical research
Antibodies for scientific purposes
Immunoassay reagents
Proteins for scientific or research use
Nucleotides for scientific and research use.
The mark was filed in class 5 with following description of goods:
Pharmaceutical products and preparations for the treatment of cancer
Pharmaceutical products and preparations for the prevention of cancer
Vaccines for the treatment of cancer
Vaccines for the prevention of cancer
Tumour antigens
Pharmaceutical preparations for the prevention or treatment of immune system related diseases and disorders
Vaccines for regulating the immune system
Vaccines for the prevention or treatment of immune system related diseases and disorders
Pharmaceutical preparations for regulating the immune system
Proteins with diagnostic and therapeutic uses
Antibodies for medical purposes.
The mark was filed in class 42 with following description of goods:
Research and development in the fields of medicine, oncology and immunology
Scientific research for medical purposes in the field of oncology
Biological research services
Pharmaceutical research services
Drug and vaccine development services
Provision of information and data relating in the fields of oncology and immunology
Consultancy, information and advisory services relating to oncology and immunology.